Dr. Zhen on Advancements in Gastroenteropancreatic Neuroendocrine Tumors

SCCA’s David Zhen, MD spoke with OncLive about advancements in the treatment of patients with gastroenteropancreatic neuroendocrine tumors.

Read the article